Ultra-widefield imaging has been shown to contribute to the benefits in the diagnosis and management of AMD.
Using ultra-widefield optomap colour and autofluorescence retinal images as part of your comprehensive ocular health. In partnership with Valeda, Optos has created a new program aimed at preventing vision loss due to Dry AMD. Studies have shown that AMD may be more than a “macular” condition but one that involves the entire retina.
Using new technology to find, test, and treat dry AMD this program offers patients with Dry AMD the hope of years of good vision.